Sohini Das

LMM expects the electrification rate among three-wheelers to rise to 55-60 per cent by 2030 from 35 per cent at present

Mahindra & Mahindra expects improved competitiveness in the US as tariffs drop to 18 per cent, plans to supply inventory from bonded warehouses

After a three-year strategic pause, diagnostics firm is unlocking its balance-sheet capacity look for growth-boosting acquisitions

Mahindra & Mahindra reports 47 per cent rise in Q3FY26 net profit to Rs 4,675 crore on record revenue; gains market share in SUVs and LCVs, tractor share steady

Digitalisation, automation and smart factories no longer a luxury for sector, it says

Tata Motors has signed an agreement to supply 70,000 commercial vehicles to Indonesia through its local subsidiary, marking the largest single international CV order, industry insiders said

Stellantis and Tata Motors Passenger Vehicles marked 20 years of their joint venture by signing a fresh MoU to explore deeper collaboration across manufacturing, engineering and supply chains

Zydus Lifesciences posted higher Q3 profit and revenue, aided by strong growth in the US and India businesses, improved margins, and steady momentum in generics, specialty and chronic segments

The tariff removal will lower prices of Harley's large-displacement imported motorcycles, which retail between ₹14.5 lakh and ₹45.8 lakh

Group would establish its largest integrated manufacturing facility for automobiles and tractors around the city

In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy

Tata Motors Passenger Vehicles slipped into a loss in Q3FY26 due to costs linked to a JLR cyber attack and regulatory provisions, even as domestic retail demand stayed robust, led by SUVs

Jaguar Land Rover will begin assembling premium cars at its new Tamil Nadu plant on February 9, marking a step towards full-scale luxury car manufacturing in India

Dr Reddy's, Biocon and Sun Pharma are exploring human-based testing methods that could halve drug development timelines and sharply reduce costs, while meeting global regulatory standards

Pune-based Emcure Pharma posted strong Q3 FY26 results on double-digit domestic and international growth, as it eyes entry into India's top 10 drugmakers

For Indian medical device exporters, the tariff reset addresses a long-standing vulnerability: wafer-thin margins

India's engineering exports to the US are set to regain momentum after reciprocal tariffs were cut to 18%, with auto component makers expected to benefit the most

Brokerages and industry bodies say easing US reciprocal tariffs to 18% will materially boost competitiveness and exports of Indian auto component makers, while gains for vehicle OEMs remain limited

Sun Pharmaceutical Industries expects pressure on its US generics business to ease as compliance improves, while focusing growth efforts on innovation-led therapies

Biopharma Shakti initiative to tackle burden of non-communicable diseases, turn India into global, innovation-led hub